[HTML][HTML] Therapeutic strategies in inflammasome mediated diseases of the liver

R Hoque, Y Vodovotz, W Mehal - Journal of hepatology, 2013 - Elsevier
… Uric acid crystals, similar to all other particulates, activate the Nlrp3 inflammasome. … ,
though a role for the Nlrp3 inflammasome in mediating ischemia reperfusion injury has …

Recent advances in the mechanisms of NLRP3 inflammasome activation and its inhibitors

Y Yang, H Wang, M Kouadir, H Song, F Shi - Cell death & disease, 2019 - nature.com
… critical roles in NLRP3 inflammasome activation. … NLRP3 inflammasome activation and
inhibitors that specifically and directly target NLRP3 to provide insights into therapeutic strategies

Therapeutic modulation of inflammasome pathways

D Chauhan, L Vande Walle… - Immunological reviews, 2020 - Wiley Online Library
… , K + efflux has been proposed as a common mechanism for NLRP3 inflammasome activation,
… pathway has gained considerable traction as a potential therapeutic strategy in Gram-…

Regulation of the NLRP3 inflammasome by post-translational modifications and small molecules

JK Seok, HC Kang, YY Cho, HS Lee… - Frontiers in …, 2021 - frontiersin.org
therapeutic strategies. To this end, there is a need to elucidate the regulatory mechanism of
NLRP3 inflammasome … in the regulation of NLRP3 inflammasome activation. Understanding …

NLRP3 inflammasome: a promising target in ischemic stroke

L Gao, Q Dong, Z Song, F Shen, J Shi, Y Li - Inflammation Research, 2017 - Springer
… However, many aspects of the biology of NLRP3 inflammasome to stroke are still not well …
the NLRP3 inflammasomes increases, opportunities to develop new therapeutic strategies for …

The NLRP3 inflammasome: role and therapeutic potential in pain treatment

H Starobova, EI Nadar, I Vetter - Frontiers in Physiology, 2020 - frontiersin.org
… arthritis, while inhibition of NLRP3 function or expression can mediate … NLRP3 inflammasome
signaling has been pathophysiologically implicated, as well as NLRP3 inflammasome-…

The NLRP3 inflammasome in non-alcoholic fatty liver disease and steatohepatitis: Therapeutic targets and treatment

L Yu, W Hong, S Lu, Y Li, Y Guan, X Weng… - Frontiers in …, 2022 - frontiersin.org
… blockade to treat NAFLD/NASH, and optimization of the therapeutic strategy for NAFLD
remains a major challenge. Future research directions should focus on agents with good results …

NLRP3 inflammasome, an immune‐inflammatory target in pathogenesis and treatment of cardiovascular diseases

Y Wang, X Liu, H Shi, Y Yu, Y Yu, M Li… - Clinical and …, 2020 - Wiley Online Library
… Thus, NLRP3 inflammasome is a key molecule involved in the pathogenesis of … NLRP3
inflammasome-based targeted therapies for CVDs and the clinical evaluation of these therapies

NLRP3 inflammasome activation contributes to the pathogenesis of rheumatoid arthritis

C Guo, R Fu, S Wang, Y Huang, X Li… - Clinical & …, 2018 - academic.oup.com
… In conclusion, NLRP3 inflammasome is involved in the pathogenesis of RA. Targeting NLRP3
inflammasome with a small molecule inhibitor might be a novel therapeutic strategy for RA…

NLRP3 inflammasome-driven pathways in depression: clinical and preclinical findings

FN Kaufmann, AP Costa, G Ghisleni, AP Diaz… - Brain, behavior, and …, 2017 - Elsevier
… system to develop new therapeutic strategies for the treatment of … The Nod-like receptor pyrin
containing 3 inflammasome (NLRP3… Recent data have demonstrated that NLRP3 activation …